El-Sayed Zeinab Awad, El-Owaidy Rasha, Hussein Shahenaz Mahmoud, Hossam Dina, El-Sawi Ihab H, Adel Ahmad, Almalky Mohamed, Elshebiny Emad, Ismaeel Ahmed Yehia, Osman Naglaa S, Shoman Walaa, Abdel Hafez Maher A, Ibrahim Mohamed Abdel-Fattah, Salama Ashraf Abdel-Baki, Sobh Ali
Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
Department of Pediatrics, Al-Azhar University-Boys, Cairo, Egypt.
Afr J Emerg Med. 2021 Dec;11(4):464-470. doi: 10.1016/j.afjem.2021.07.005. Epub 2021 Oct 28.
Early recognition of an anaphylaxis event is crucial for instituting lifesaving management. We sought to explore knowledge and practice towards anaphylaxis in a sample of physicians from ten Egyptian governorates.
An eighteen question-based questionnaire was developed by expert allergists to evaluate the knowledge and practice towards anaphylaxis, based on the World Allergy Organization guidelines for the assessment and management of anaphylaxis. The questionnaires were distributed, and the answered forms collected via emails, and data were tabulated, and analysed.
In this cross-sectional study, a total of 242 physicians completed the survey (183 (75.6%) paediatricians, 32 (13.2%) internists, 22 (9.1%) intensivists and five (2.1%) anaesthetists). Only 91 participants (37.6%) identified all the four proposed anaphylaxis clinical scenarios while 70, 45 and 36 identified three, two and one scenario, respectively. Loss of consciousness and abdominal symptoms were not recognised as possible presentations of anaphylaxis by 64.5% and 80.2% of the participants, respectively. Epinephrine was considered the first line treatment by 98 (40.5%), corticosteroids by 77 (31.8%) and antihistamines by 25 (10.3%). 75 (31%) responders identified the right dose of epinephrine while 119 (49.2%) identified the proper route. Concerning practice, 83 physicians (39.2%) used epinephrine for all cases of anaphylaxis, 88 (41.5%) used it for refractory cases only whereas 41 (19.3%) did not use epinephrine at all.
Our survey shows that the knowledge of Egyptian physicians and their practice towards anaphylaxis are still inadequate. The current situation reinforces the need to disseminate and encourage the adoption of the international guidelines for anaphylaxis diagnosis and treatment.
早期识别过敏反应事件对于实施挽救生命的治疗至关重要。我们试图在来自埃及十个省份的一组医生中探索他们对过敏反应的认知和实践情况。
由过敏症专家开发了一份包含18个问题的问卷,根据世界过敏组织的过敏反应评估和管理指南来评估对过敏反应的认知和实践情况。问卷进行了分发,并通过电子邮件收集已填写的表格,然后将数据制成表格并进行分析。
在这项横断面研究中,共有242名医生完成了调查(183名(75.6%)儿科医生、32名(13.2%)内科医生、22名(9.1%)重症监护医生和5名(2.1%)麻醉医生)。只有91名参与者(37.6%)识别出了所有四种提出的过敏反应临床场景,而分别有70名、45名和36名参与者识别出了三种、两种和一种场景。分别有64.5%和80.2%的参与者未将意识丧失和腹部症状视为过敏反应的可能表现。98名(40.5%)参与者认为肾上腺素是一线治疗药物,77名(31.8%)认为是皮质类固醇,25名(10.3%)认为是抗组胺药。75名(31%)应答者确定了正确的肾上腺素剂量,119名(49.2%)确定了正确的给药途径。在实践方面,83名医生(39.2%)对所有过敏反应病例都使用肾上腺素,88名(41.5%)仅对难治性病例使用,而41名(19.3%)根本不使用肾上腺素。
我们的调查表明,埃及医生对过敏反应的认知及其实践仍然不足。当前的情况强化了传播和鼓励采用国际过敏反应诊断和治疗指南的必要性。